• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

FAM83H-AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma.

广告
第一作者: Siwei,Wang
第一单位: Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
作者: Siwei,Wang [1] ; Chencheng,Han [1] ; Tongyan,Liu [2] ; Zhifei,Ma [1] ; Mantang,Qiu [3] ; Jie,Wang [4] ; Qingjun,You [5] ; Xiufen,Zheng [1] ; Weizhang,Xu [1] ; Wenjia,Xia [1] ; Youtao,Xu [1] ; Jingwen,Hu [1] ; Lin,Xu [6] ; Rong,Yin [7]
作者单位: Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China. [1] Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.;Department of Science and technology, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China. [2] Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China. [3] Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.;Department of Science and technology, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.;Biobank of Lung Cancer, Jiangsu Biobank of Clinical Resources, Nanjing, China. [4] Department of Thoracic Surgery, The Affiliated Hospital of Jiangnan University, Wuxi, China. [5] Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China. [6] Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.;Department of Science and technology, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.;Biobank of Lung Cancer, Jiangsu Biobank of Clinical Resources, Nanjing, China.;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China. [7]
DOI 10.1002/ctm2.316
PMID 33634993
发布时间 2024-03-30
提交
  • 浏览0
Clinical and translational medicine

Clinical and translational medicine

2021年11卷2期

e316页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷